NASDAQ:AVRO
AVROBIO Inc Stock News
$1.26
+0.0100 (+0.80%)
At Close: May 08, 2024
Eyes On Coronavirus, Alibaba, Samsung And Overstock.com
01:38pm, Saturday, 08'th Feb 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Key events next week - healthcare
02:47pm, Friday, 07'th Feb 2020
Noteworthy events during the week of February 9 - 15 for healthcare investors.MONDAY (2/10): Global NASH Congress, London (2 days).WORLDSymposium, Orlando, FL (4 days). REGENXBIO (NASDAQ:RGNX): Phase
Vor Biopharma Completes $42M Series A Financing | FinSMEs
05:56pm, Thursday, 14'th Feb 2019
Vor Biopharma, an immuno-oncology company pioneering engineered hematopoietic stem cell therapies to treat hematological malignancies, raised $42m
10-year highs: Aus shares 0.4% higher at noon
07:10am, Tuesday, 08'th May 2018
08 May 2018 - Market at Midday: ASX200 back at 10-year highs. Retail trade remained steady in March in seasonally adjusted terms, disappointing economists who expected a rise of 0.3 per cent. Federal
CAR:T - Has biology outpaced the ability to deliver? -
01:32pm, Friday, 08'th Dec 2017
Experts comment on manufacturing of CAR-T
TXCELL nomme un expert de la thérapie génique à son Conseil scientifique
06:35am, Thursday, 25'th Aug 2016
(AOF) - TxCell, société de biotechnologies qui développe des immunothérapies cellulaires personnalisées innovantes à partir de cellules T régulatrices (Treg) pour le traitement de maladies infl